Acute Helicobacter pylori Infection Prevalence Among Renal Failure Patients and Its Potential Roles with Other Chronic Diseases: A Retrospective Cohort Study

References

• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–3044. doi:10.1002/ijc.21731
   PubMed Web of Science ®Google Scholar
• Gravina AG, Zagari RM, De Musis C, et al. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2018;24:3204. doi:10.3748/WJG.V24.I29.3204
   PubMed Web of Science ®Google Scholar
• Jiang J, Chen Y, Shi J, et al. Population attributable burden of Helicobacter pylori-related gastric cancer, coronary heart disease, and ischemic stroke in China. Eur J Clin Microbiol Infect Dis. 2017;36:199–212. doi:10.1007/S10096-016-2810-X
   Web of Science ®Google Scholar
• Pan W, Zhang H, Wang L, et al. Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer. Ren Fail. 2019;41:1028–1034. doi:10.1080/0886022X.2019.1683029
   PubMed Web of Science ®Google Scholar
• Zizzi CF, Pellicano R, Biancone L. The relationship between Helicobacter pylori and chronic kidney disease: update 2020. Minerva Gastroenterol Dietol. 2020;66:343–349. doi:10.23736/S1121-421X.20.02729-4
   Web of Science ®Google Scholar
• Ranjbar R, Behzadi P, Farshad S. Advances in diagnosis and treatment of Helicobacter pylori infection. Acta Microbiol Immunol Hung. 2017;64:273–292. doi:10.1556/030.64.2017.008
   PubMed Web of Science ®Google Scholar
• Nagaraja P, Ghalli F. Renal Failure. Blandy’s Urology. 2019;117–126. doi:10.1002/9781118863343.ch7
   Google Scholar
• Hilton R. Acute renal failure. BMJ. 2006;333:786–790. doi:10.1136/bmj.38975.657639.AE
   PubMed Web of Science ®Google Scholar
• Webster AC, Nagler EV, Morton RL, et al. Chronic Kidney Disease. Lancet. 2017;389:1238–1252. doi:10.1016/S0140-6736(16)32064-5
   PubMed Web of Science ®Google Scholar
• Perneger TV, Brancati FL, Whelton PK, et al. Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions. Am J Kidney Dis. 1995;25:722–731. doi:10.1016/0272-6386(95)90548-0
   PubMed Web of Science ®Google Scholar
• Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl. 2013;3:368–371. doi:10.1038/kisup.2013.79
   PubMed Web of Science ®Google Scholar
• Araki H, Miyazaki R, Matsuda T, et al. Significance of serum pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients. Nephrol Dial Transplant. 1999;14:2669–2675. doi:10.1093/NDT/14.11.2669
   Web of Science ®Google Scholar
• Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet. 1986;2:15–17. doi:10.1016/s0140-6736(86)92561-4
   PubMed Web of Science ®Google Scholar
• Gladziwa U, Haase G, Handt S, et al. Prevalence of Helicobacter pylori in patients with chronic renal failure. Nephrol Dial Transplant. 1993;8:301–306. doi:10.1007/s40620-020-00808-y
   PubMed Web of Science ®Google Scholar
• Aydemir S, Boyacioglu S, Gur G, et al. Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. World J Gastroenterol. 2005;11:842–845. doi:10.3748/WJG.V11.I6.842
   PubMed Web of Science ®Google Scholar
• Schoonjans R, Van Vlem B, Vandamme W, et al. Dyspepsia and gastroparesis in chronic renal failure: the role of Helicobacter pylori. Clin Nephrol. 2002;57:201–207. doi:10.5414/CNP57201
   PubMed Web of Science ®Google Scholar
• Mousa D, Alharbi A, Helal I, et al. Prevalence and Associated Factors of Chronic Kidney Disease among Relatives of Hemodialysis Patients in Saudi Arabia. Kidney Int Reports. 2021;6:817–820. doi:10.1016/J.EKIR.2020.12.029/ATTACHMENT/BAA9DCFE-8AF4-4E0A-B684-76AA3E24BE42/MMC1.DOCX
   Web of Science ®Google Scholar
• Alsuwaida AO, Farag YMK, Al Sayyari AA, et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl. 2010;21:1066–1072.
   PubMedGoogle Scholar
• Akeel M, Elmakki E, Shehata A, et al. Prevalence and factors associated with H. pylori infection in Saudi patients with dyspepsia. Electron Physician. 2018;10:7279. doi:10.19082/7279
   Google Scholar
• Mahallawi WH, Ibrahim NA, Mumena WA. Effectiveness of COVID-19 Vaccines in Patients Under Maintenance Hemodialysis. Risk Manag Healthc Policy. 2021;14:5081. doi:10.2147/RMHP.S345686
   Web of Science ®Google Scholar
• Gatta L, Vakil N, Ricci C, et al. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004;99:823–829. doi:10.1111/J.1572-0241.2004.30162.X
   PubMed Web of Science ®Google Scholar
• Alem M, Alem N, Cohen H, et al. Diagnostic value of detection of IgM antibodies to Helicobacter pylori. Exp Mol Pathol. 2002;72:77–83. doi:10.1006/EXMP.2001.2408
   Web of Science ®Google Scholar
• Eastham EJ, Elliott TSJ, Berkeley D, et al. Campylobacter pylori infection in children. J Infect. 1988;16:96205–96206. doi:10.1016/S0163-4453(88)
   Web of Science ®Google Scholar
• Özgür O, Boyacioǧlu S, Özdoǧan M, et al. Helicobacter pylori infection in haemodialysis patients and renal transplant recipients. Nephrol Dial Transplant. 1997;12:289–291. doi:10.1093/NDT/12.2.289
   PubMed Web of Science ®Google Scholar
• Shousha S, Arnaout AH, Abbas SH, et al. Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol. 1990;43:397–399. doi:10.1136/JCP.43.5.397
   PubMed Web of Science ®Google Scholar
• Asl MKH, Nasri H. Prevalence of Helicobacter pylori infection in maintenance hemodialysis patients with non-ulcer dyspepsia. Saudi J Kidney Dis Transpl. 2009;20:223–226.
   Google Scholar
• Lin SY, Lin CL, Liu JH, et al. Association between Helicobacter pylori infection and the subsequent risk of end-stage renal disease: a nationwide population-based cohort study. Int J Clin Pract. 2015;69:604–610. doi:10.1111/IJCP.12602
   PubMed Web of Science ®Google Scholar
• Nagashima R, Maeda K, Yuda F, et al. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch. 1997;431(4):235–239. doi:10.1007/S004280050094
   PubMed Web of Science ®Google Scholar
• Liu XZ, Zhang YM, Jia NY, et al. Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy. Ren Fail. 2020;42:539. doi:10.1080/0886022X.2020.1772295
   PubMed Web of Science ®Google Scholar
• Zhu TT, Wang L, Wang HL, et al. Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail. 2016;38:1398–1404. doi:10.1080/0886022X.2016.1216713
   PubMed Web of Science ®Google Scholar
• Nesheiwat Z, Daboul J, Merugu GP, et al. Membranous nephropathy and autoimmune hepatitis in the setting of acute Helicobacter pylori infection: a case report. J Med Case Rep. 2021;15. doi:10.1186/S13256-021-02874-7
   Google Scholar
• Wu MC, Leong PY, Chiou JY, et al. Increased Risk of Systemic Lupus Erythematosus in Patients With Helicobacter pylori Infection: a Nationwide Population-Based Cohort Study. Front Med. 2020;6:330. doi:10.3389/FMED.2019.00330/XML/NLM
   Web of Science ®Google Scholar
• Wang F, Liu J, Lv Z. Association of Helicobacter pylori infection with diabetes mellitus and diabetic nephropathy: a meta-analysis of 39 studies involving more than 20,000 participants. Scand J Infect Dis. 2013;45:930–938. doi:10.3109/00365548.2013.844351
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhong X, Chen J, et al. Helicobacter pylori infection associated with type 2 diabetic nephropathy in patients with dyspeptic symptoms. Diabetes Res Clin Pract. 2015;110:328–334. doi:10.1016/J.DIABRES.2015.09.008
   Web of Science ®Google Scholar
• Moriyama T, Kaneko T, Fujii M, et al. High prevalence of Helicobacter pylori infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther Symp Ser. 2006;2:189–193. doi:10.1111/J.1746-6342.2006.00044.X
   Google Scholar
• Li Q, Lin X, Wu Z, et al. Immuno-histochemistry analysis of Helicobacter pylori antigen in renal biopsy specimens from patients with glomerulonephritis. Saudi J Kidney Dis Transpl. 2013;24:751–758. doi:10.4103/1319-2442.113871
   PubMedGoogle Scholar
• Aydogan T, Ulas T, Selcoki Y, et al. Effects of Helicobacter pylori eradication on proteinuria: a prospective study. Wien Klin Wochenschr. 2012;124:241–244. doi:10.1007/S00508-012-0150-0
   PubMed Web of Science ®Google Scholar
• Kanbay M, Kasapoglu B, Akcay A. An occult risk factor for proteinuria: helicobacter pylori infection. Med Hypotheses. 2007;69:709–710. doi:10.1016/J.MEHY.2007.01.010
   PubMed Web of Science ®Google Scholar
• Afsar B, Ozdemir FN, Elsurer R, et al. Helicobacter pylori infection may increase renal resistive index. Med Hypotheses. 2007;69:956–957. doi:10.1016/J.MEHY.2007.01.061
   Web of Science ®Google Scholar
• Jaspersen D, Fassbinder W, Heinkele P, et al. Significantly lower prevalence of Helicobacter pylori in uremic patients than in patients with normal renal function. J Gastroenterol. 1995;30:585–588. doi:10.1007/BF02367783
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Sakai K, Kita M, et al. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75:96–103. doi:10.1038/KI.2008.508
   PubMed Web of Science ®Google Scholar
• Seyrek N, Kocabas E, Hazar S, et al. Helicobacter pylori antibodies in patients on chronic hemodialysis. Nephron. 1996;72:725–726. doi:10.1159/000188978
   Web of Science ®Google Scholar
• Nakajima F, Sakaguchi M, Amemoto K, et al. Helicobacter pylori in patients receiving long-term dialysis. Am J Nephrol. 2002;22:468–472. doi:10.1159/000065278
   PubMed Web of Science ®Google Scholar
• Pan W, Zhang H, Wang L, et al. Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer. Ren Fail. 2019;41:1028. doi:10.1080/0886022X.2019.1683029
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Furukawa T, Maeda T, et al. Marked reduction of proteinuria after eradication of gastric Helicobacter pylori infection in a patient with membranous nephropathy: coincidental or associated? Intern Med. 2007;46:1483–1484. doi:10.2169/INTERNALMEDICINE.46.0200
   PubMed Web of Science ®Google Scholar
• Aljahdli E, Almaghrabi SJ, Alhejaili TL, et al. Association Between Helicobacter pylori Eradication and Kidney Function in Patients With Chronic Gastritis: a Retrospective Single-Center Study. Cureus. 2022;14. doi:10.7759/CUREUS.21621
   Web of Science ®Google Scholar
• Pilotto A, Salles N. Helicobacter pylori infection in geriatrics. Helicobacter. 2002;7(Suppl 1):56–62. doi:10.1046/J.1523-5378.7.S1.9.X
   PubMed Web of Science ®Google Scholar
• Regev A, Fraser GM, Braun M, et al. Seroprevalence of Helicobacter pylori and length of stay in a nursing home. Helicobacter. 1999;4:89–93. doi:10.1046/J.1523-5378.1999.98640.X
   PubMed Web of Science ®Google Scholar
• Pilotto A, Fabrello R, Franceschi M, et al. Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status. Age Ageing. 1996;25:245–249. doi:10.1093/AGEING/25.3.245
   PubMed Web of Science ®Google Scholar
• Xiong X, Chen J, He M, et al. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults: the Dongfeng-Tongji cohort. Int J Med. 2020;22:1389–1395. doi:10.1111/jch.13928
   Web of Science ®Google Scholar
• Wan Z, Hu L, Hu M, et al. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults. J Hum Hypertens. 2018;32:158–164. doi:10.1038/S41371-017-0028-8
   PubMed Web of Science ®Google Scholar
• Gobert AP, Mersey BD, Cheng Y, et al. Cutting Edge: urease Release by Helicobacter pylori Stimulates Macrophage Inducible Nitric Oxide Synthase. J Immunol. 2002;168:6002–6006. doi:10.4049/JIMMUNOL.168.12.6002
   Web of Science ®Google Scholar
• Kountouras J, Papaefthymiou A, Polyzos SA, et al. Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. Microorg. 2021;9:2351. doi:10.3390/MICROORGANISMS9112351
   Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111–1119. doi:10.1172/JCI25102
   PubMed Web of Science ®Google Scholar
• Migneco A, Ojetti V, Specchia L, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter. 2003;8:585–589. doi:10.1111/j.1523-5378.2003.00180.x
   PubMed Web of Science ®Google Scholar
• Kopáčová M, Bureš J, Koupil I, et al. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol. 2007;22:67–75. doi:10.1007/S10654-006-9090-1
   PubMed Web of Science ®Google Scholar
• Chronopoulos A, Trudeau K, Roy S, et al. High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy. Curr Eye Res. 2011;36:747–753. doi:10.3109/02713683.2011.585735
   PubMed Web of Science ®Google Scholar
• Morss AS, Edelman ER. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem. 2007;282:14635–14644. doi:10.1074/JBC.M608565200
   PubMed Web of Science ®Google Scholar
• Aslan M, Horoz M, Nazligul Y, et al. Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol. 2006;12:6865. doi:10.3748/WJG.V12.I42.6865
   Web of Science ®Google Scholar
• Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2017;12:2032–2045. doi:10.2215/CJN.11491116.
   PubMed Web of Science ®Google Scholar
• Cheng KP, Yang YJ, Hung HC, et al. Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection. J Diabetes Investig. 2019;10:1092–1101. doi:10.1111/JDI.12991
   Web of Science ®Google Scholar